Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class ASSE: 688621

"Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Announcement of Voluntary Disclosure of Semi-annual Performance Forecast for 2026

· Issued by Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A via Shanghai Stock Exchange
Announcement of Voluntary Disclosure of Semi-annual Performance Forecast for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A

All Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A news releases